Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Validation of the STOPSHOCK Score - Artificial Intelligence Based Predictive Scoring System to Identify the Risk of Developing Cardiogenic Shock (CS) in Patients Suffering From Acute Coronary Syndrome (ACS)

NCT07090382 is registered in ClinicalTrials.gov with Premedix Academy as lead sponsor.

NCT NCT07090382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07090382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Validation of the STOPSHOCK Score - Artificial Intelligence Based Predictive Scoring System to Identify the Risk of Developing Cardiogenic Shock (CS) in Patients Suffering From Acute Coronary Syndrome (ACS)
Lead sponsor
Premedix Academy
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 1, 2025
Completion date
April 30, 2026
Enrollment
1,046 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome (acs) undergoing percutaneous coronary intervention (pci), cardiogenic shock, cardiogenic shock acute, cardiogenic shock post myocardial infarction, pci